Prediction of Quality of Life in Patients With Parkinson's Disease With and Without Excessive Daytime Sleepiness: A Longitudinal Study

Lixia Zhang; Yajing Chen; Xiaoniu Liang; Lan Wang; Jian Wang; Yilin Tang; Xiaodong Zhu

doi:10.3389/fnagi.2022.846563

Prediction of Quality of Life in Patients With Parkinson's Disease With and Without Excessive Daytime Sleepiness: A Longitudinal Study

Front Aging Neurosci. 2022 Apr 13:14:846563. doi: 10.3389/fnagi.2022.846563. eCollection 2022.

Authors

Lixia Zhang¹, Yajing Chen², Xiaoniu Liang³, Lan Wang⁴, Jian Wang³, Yilin Tang³, Xiaodong Zhu⁵

Affiliations

¹ Department of Neurology, Taizhou Second People's Hospital, Taizhou, China.
² Department of Neurology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
³ Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
⁴ Department of Neurology, Nanjing Drum Tower Hospital, Nanjing, China.
⁵ Department of Neurology, Tianjin Medical University General Hospital, Tianjin, China.

Abstract

Objective: There is a lack of longitudinal studies that directly compare the quality of life (QoL) and investigate the impact of clinical factors on QoL across different excessive daytime sleepiness (EDS) statuses in Parkinson's disease (PD); therefore, we aimed to compare QoL and reveal the potential heterogeneous predictors of QoL between patients with PD with and without EDS.

Methods: We collected clinical data among 306 patients with PD over 2 years. EDS was assessed by the Epworth Sleepiness Scale and QoL was measured with the 39-item Parkinson's Disease Questionnaire.

Results: We found that at both baseline and follow-up, patients with PD with EDS had poorer QoL and suffered more non-motor symptoms including depression and clinical probable rapid eye movement sleep behavior disorder (cpRBD). The generalized linear mixed model analysis indicated that the major predictors of QoL in PD with EDS were the akinetic-rigid type, disease duration, and total levodopa equivalent dose, while in PD without EDS, the primary determinants of QoL were Hoehn and Yahr, Mini-Mental State Examination (MMSE), and cpRBD.

Conclusion: Patients with PD with EDS presented with poorer QoL. Besides, the baseline predictors of future QoL differed between patients with PD with and without EDS. These findings remind clinicians to target specific clinical factors when attempting to improve QoL among patients with PD.

Keywords: Parkinson’s disease; excessive daytime sleepiness; motor subtype; non-motor symptoms; quality of life.